Avloclav 1.2 IV Injection Injection

About Avloclav 1.2 IV Injection 1 gm + 200 mg

Avloclav 1.2 IV Injection, from Advanced Chemical Industries PLC, combines amoxicillin and clavulanic acid. It is a broad-spectrum penicillin antibiotic given by injection for bacterial infections.

There are 105 brands of Amoxicillin + Clavulanic Acid listed in Bangladesh. The lowest listed price is Moxilin CV 125 mg + 31.25 mg/5 ml Powder For Suspension at ৳ 1 per unit.

What is Avloclav 1.2 IV Injection 1 gm + 200 mg?

Avloclav 1.2 IV Injection is a prescription antibiotic made by Advanced Chemical Industries PLC. It contains amoxicillin, a penicillin antibiotic, and clavulanic acid, which blocks certain enzymes that bacteria use to resist penicillins. The combination is active against many bacteria that cause respiratory, urinary and other infections. This injection is for hospital or clinic use under medical supervision. The dose and course are set by the doctor based on the infection and the patient's condition. It is not for self-medication. Tell the doctor about any penicillin allergy or liver problems before treatment.

Uses of Avloclav 1.2 IV Injection

Doctors prescribe Avloclav 1.2 IV Injection for short-term treatment of bacterial infections in several sites, including upper respiratory tract infections such as tonsillitis, sinusitis and otitis media; lower respiratory tract infections such as acute and chronic bronchitis and pneumonia; and genito-urinary tract infections such as cystitis and urethritis. It is not for viral infections like colds or flu.

How to use Avloclav 1.2 IV Injection

Avloclav 1.2 IV Injection is given by a healthcare professional as an intravenous injection or infusion, usually in a hospital or clinic. The doctor decides the dose, how often it is given, and how long the course lasts. Do not attempt to use it yourself. If you have questions about your treatment, ask your doctor or pharmacist.

Side effects of Avloclav 1.2 IV Injection

Side effects are usually mild and temporary. Common ones include diarrhoea, indigestion, nausea, vomiting and candidiasis. Pseudomembranous colitis has been reported. Skin rashes such as urticaria and erythematous rash can occur. Rarely, hepatitis, cholestatic jaundice, erythema multiforme, Stevens-Johnson syndrome and exfoliative dermatitis have been reported. Allergic reactions including angioedema and anaphylaxis can occur. Seek medical help if you have a severe reaction.

Safety and precautions

Avloclav 1.2 IV Injection must be used with caution in people on anticoagulation therapy or with severe liver problems. Dose adjustment is needed for moderate or severe kidney impairment. It is not recommended in pregnancy unless the doctor considers it essential; small amounts of amoxicillin can pass into breast milk. Do not use it if you have had a penicillin allergy or previous cholestatic jaundice with co-amoxiclav. Tell your doctor about allergies, kidney or liver disease, and other medicines before treatment.

Frequently asked questions

How is Avloclav 1.2 IV Injection taken?

It is given by a healthcare professional as an intravenous injection or infusion, usually in a hospital or clinic. The doctor decides the dose, frequency and length of the course. Do not self-administer. Ask your doctor or pharmacist if you have questions about how it will be given.

What is Avloclav 1.2 IV Injection used for and what kind of medicine is it?

It is a broad-spectrum penicillin antibiotic combining amoxicillin and clavulanic acid. It is used for short-term treatment of bacterial infections of the upper and lower respiratory tract and the genito-urinary tract. It does not treat viral infections.

What does the generic name mean?

The generic name is Amoxicillin + Clavulanic Acid. Amoxicillin is a penicillin antibiotic that kills many bacteria. Clavulanic acid blocks enzymes called beta-lactamases that some bacteria produce to resist penicillins. Together they extend the antibiotic's activity against certain resistant bacteria.

Who should ask a doctor first before using this injection?

Anyone with a history of penicillin or other beta-lactam allergy, liver problems, kidney impairment, or who is pregnant or breastfeeding should speak to the doctor first. Also tell the doctor about all other medicines you take, especially blood thinners, so the treatment can be managed safely.

Indications

Co-amoxiclav is indicated for short-term treatment of bacterial infections at the following sites:
  • Upper respiratory tract infections (including ENT) e.g.tonsillitis,sinusitis,otitis media.
  • Lower respiratory tract infections e.g.acute and chronic bronchitis, lobar and bronchopneumonia.
  • ... Read more
Co-amoxiclav is indicated for short-term treatment of bacterial infections at the following sites:
  • Upper respiratory tract infections (including ENT) e.g.tonsillitis,sinusitis,otitis media.
  • Lower respiratory tract infections e.g.acute and chronic bronchitis, lobar and bronchopneumonia.
  • Genito-urinary tract infections e.g.cystitis,urethritis,pyelonephritis.
  • Skin and soft tissue infections.
  • Bone and joint infections e.g.osteomyelitis.
  • Other infections e.g.septic abortion,puerperal sepsis,intra-abdominal sepsis etc.

Pharmacology

Pharmacodynamic properties: Co-amoxiclav is an antibacterial combination consisting of the antibiotic Amoxicillin and the (3-lactamase inhibitor Clavulanic Acid. Amoxicillin has a broad spectrum of bactericidal activity against many Gram-positive & Gram-negative microorganisms but it is susceptible to degradation by (3-lactamases and therefore the spectrum of activity does not include microorganisms, which produce these enzymes. Clavulanic acid possesses the ability to inactivate a wide range of beta-lactamase enzymes commonly found in microorganisms resistant to penicillins and cephalosporins. Thus Clavulanic acid in this preparation protects Amoxicillin from degradation by (3-lactamase enzymes and effectively extends the antibiotic spectrum to embrace a wide range of microorganisms.

Pharmacokinetic properties: The pharmacokinetics of the two components of Co-amoxiclav is closely matched. Peak serum levels of both occur about one hour after oral administration. Absorption of Co-amoxiclav is optimized at the start of a meal. Both clavulanate and Amoxicillin have low levels of serum binding; about 70% remains free in the serum. Doubling the dosage of Co-amoxiclav approximately doubles the serum levels achieved.

Dosage & Administration

Adults and children over 12 years:

Tablet:
  • The usual adult dose is one 625 mg Tablet every 12 hours or one 375 mg Tablet every 8 hours.
  • For more severe infections and infections of the respiratory tract, the dose should be one 1 gm Tablet every 12 hours or one 625 mg Tablet every 8 hours.
Suspension:
  • Children 6-12 years: 2 teaspoonful every 8 hours.
  • Children 1-6years: 1 teaspoonful every 8 hours.
  • Children below 1 year: 25 mg/kg/day in divided doses every 8 hours, for example a 7.5 kg child would require 2 ml suspension t.i.d, Treatment should not be extended beyond 14 days without review.
Forte suspension:
  • The usual recommended daily dosage: 25/3.6 mg/kg/day in mild to moderate infections (upper respiratory tract infections e.g. recurrent tonsilitis, lower respiratory infections, and skin and soft tissue infections)।
  • For serious infections: 45/6.4 mg/kg/day for the treatment of more serious infections (upper respiratory tract infections, e.g. otitis media and sinusitis, lower respiratory infections e.g. bronchopneumonia, and urinary tract infections).
Children of 2 to 12 years:
Mild to moderate infections:
  • 25/3.6 mg/kg/day (Suspension)
  • 2-6 years (13-21 kg) 2.5 ml suspension b.i.d
  • 7-12years (22-40kg) 5 ml suspension b.i.d
Serious infections:
  • 45/6.4 mg/kg/day (Forte Suspension)
  • 2-6 years (13-21 kg) 5 ml suspension b.i.d
  • 7-12 years (22-40 kg) 10 ml suspension b.i.d
IV Injection

Adults-
  • Usually, 1.2 gm every 8 hours
  • Increased in more serious infections to 1.2 gm every 6 hours
  • For surgical prophylaxis: The usual dose is 1.2 gm at induction, for high risk procedures (eg. colorectal surgery) up to 2-3 gm may be given every 8 hours.
Children-
  • 0 to 3 months: 30 mg/kg every 8 hours. (every 12 hours in the perinatal period and in premature infants.
  • 3 months to 12 years: Usually 30 mg/kg every 8 hours increased in more serious infection to 30 mg/kg every 6 hours.

Interaction

Prolongation of bleeding time and prothrombin time have been reported in some patients receiving Co-amoxiclav. In common with other broad-spectrum antibiotics, Co-amoxiclav may reduce the efficacy of oral contraceptives and patients should be warned accordingly. Concomitant use of allopurinol during treatment with amoxicillin can increase the likelihood of allergic skin reactions. There are no data on the concomitant use of Co-amoxiclav and allopurinol.

Contraindications

History of Penicillin hypersensitivity. Attention should be paid to possible cross-sensitivity with other beta-lactam antibiotics e.g. cephalosporins. Also contraindicated for patients with a previous history of Co-amoxiclav or Penicillin-associated cholestatic jaundice.

Side Effects

Side effects, as with Amoxicillin, are uncommon and mainly of a mild and transitory nature. Diarrhoea, pseudomembranous colitis, indigestion, nausea, vomiting and candidiasis have been reported, if gastrointestinal side effects occur with oral therapy, that may be reduced by taking Co-amoxiclav at the start of meals. Hepatitis and cholestatic jaundice have been reported rarely but are usually reversible. Urticarial and erythematous rashes sometimes occur. Rarely erythema multiforme, Stevens-Johnson Syndrome and exfoliative dermatitis have been reported. In common with other beta-lactam antibiotics, angioedema and anaphylaxis have been reported.

Pregnancy & Lactation

Animal studies with orally and parenterally administered Co-amoxiclav have shown no teratogenic effect. The drug has been used orally in human pregnancy in a limited number of cases with no untoward effect; however, the use of Co-amoxiclav in pregnancy is not recommended unless considered essential by the physician. During lactation, trace quantities of Amoxicillin can be detected in breast milk.

Precautions & Warnings

Co-amoxiclav should be used with care in patients on anticoagulation therapy or with severe hepatic dysfunction. In patients with moderate or severe renal impairment, dosage should be adjusted. During the administration of a high dose of Co-amoxiclav adequate fluid intake and urinary output should be maintained to minimize the possibility of crystalluria.

Overdose Effects

Problems of overdose with Co-amoxiclav are unlikely to occur, if encountered gastrointestinal symptoms and disturbance of the fluid and electrolyte balances may be evident. Co-amoxiclav may be removed from the circulation by haemodialysis.

Storage Conditions

This should be stored below 25°C, protected from light and moisture. Once reconstituted suspension should be kept in the refrigerator (but not frozen) and should be usedby 7 days. Once reconstituted vial must be used within 20 minutes.

Alternative brands of Amoxicillin + Clavulanic Acid

Other brands with the same generic name, cheapest first.

See all 105 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.